Microtubule Inhibitor
5 drugs across 2 manufacturers|5 Generic,0 Brand
The Microtubule Inhibitor class contains 5 NDCs from 2 manufacturers (5 generic, 0 brand), at an average NADAC of $1.89 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
5
5G / 0B
Manufacturers
2
Avg $1.8895/unit
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
of 5 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PACLITAXEL 30 MG/5 ML VIAL PACLITAXEL | $2.1290 per ML | — |
PACLITAXEL 100 MG/16.7 ML VIAL PACLITAXEL | $1.8891 per ML | — |
PACLITAXEL 100 MG/16.7 ML VIAL Paclitaxel | $1.8891 per ML | — |
PACLITAXEL 300 MG/50 ML VIAL PACLITAXEL | $1.7700 per ML | — |
PACLITAXEL 300 MG/50 ML VIAL Paclitaxel | $1.7700 per ML | — |
Frequently Asked Questions
How many drugs are in the Microtubule Inhibitor class?
The Microtubule Inhibitor class contains 5 NDCs from 2 manufacturers — 5 generic and 0 brand products.
What is the average price of Microtubule Inhibitor drugs?
The average NADAC for the Microtubule Inhibitor class is $1.8895 per unit across 5 NDCs.
Which manufacturers make Microtubule Inhibitor drugs?
2 manufacturers make drugs in the Microtubule Inhibitor class. Ranked by number of NDCs, the largest are Hospira Inc. (3), Fresenius Kabi USA, LLC (2).